TH2 cytokine-enhanced and TGF-β-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-γ and corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1307-1318

  Wen, Fu Qiang ^a   Liu, Xiangde ^a   Manda, Winfred ^a   Terasaki, Yusuke ^a   Kobayashi, Tetsu ^a   Abe, Shinji ^a   Fang, Qiuhong ^a   Ertl, Ronald ^a   Manouilova, Lidia ^a   Rennard, Stephen I ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Corticosteroids; Human airway smooth muscle cells; TH2 TH1 cytokines; Transforming growth factor ; Vascular endothelial growth factor

Indexed keywords

BUDESONIDE; CORTICOSTEROID DERIVATIVE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 1; LYMPHOKINE; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ARTICLE; ASTHMA; CELL ASSAY; CELL CULTURE; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; TH2 CELL; TIME; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LUNG; METABOLISM; SMOOTH MUSCLE;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; INTERLEUKIN-1; LUNG; LYMPHOKINES; MUSCLE, SMOOTH; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038518094     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1455     Document Type: Article

References (54)

1. Ferrara N. Davis-Smyth T The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
2. Leung DW, Cachianes G. Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
3. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301.
4. Ray A, Cohn L. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J Clin Invest 1999;104:985-93.
5. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C. Azzarone B. Interleukin (IL)4 and IL-13 act on human lung fibre-blasts. J Clin Invest 1998;101:2129-39.
6. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion. subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88.
7. Wen FQ, Kohyama T, Liu X, Zhu YK, Wang H, Kim H J, et al. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 2002;26:484-90.
8. Lee CG, Homer RJ, Cohn L, Link H, Jung S. Craft JE. et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002;277:35466-74.
9. Cohn L, Herrick C, Niu N, Homer R, Bottomly K. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J Immunol 2001;166:2760-7.
10. Ziesche R, Hofbauer E. Wittmann K, Petkov V. Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-9.
11. Pang L, Knox AJ. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol 1997;121:579-87.
12. Pang L. Knox AJ. PGE2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am J Physiol 1997;273:L1132-40.
13. Pang L, Knox AJ. Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol 1998;161:2509-15.
14. Pang L, Knox AJ. Regulation of TNF-alpha-induccd eotaxin release from cultured human airway smooth muscle cells by bcta2-agonists and corticosteroids. FASEB J 2001;15:261-9.
15. John M, Hirst S J, Jose PJ, Robichaud A, Berkman N, Witt C, et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 1997;158:1841-7.
16. Zhu YK, Liu X, Wang H, Kohyama T, Wen FQ, Skold CM, et al. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. J Allergy Clin Immunol 2001;108:989-96.
17. Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, Pang L. Human airway smooth muscle cells secrete vascular endothelial growth factor: upregulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J 2001;15:2480-8.
18. Panettieri RA, Murray RK, DePalo LR, Yadvish PA, Kotlikoff MI. A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol 1989;256:C329-35.
19. Hall IP, Kotlikoff M. Use of cultured airway myocytes for study of airway smooth muscle. Am J Physiol 1995;268:L1-11.
20. Liu X, Kohyama T, Wang H, Zhu YK, Wen FQ, Kim HJ, et al. Th2 cytokine regulation of type 1 collagen gel contraction mediated by human lung mesenchymal cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L1049-56.
21. O'Donnell RA, Davis DE, Holgate ST. Airway remodeling. In: Barnes P, Drazen J, Rennard SI, Thomson N, editors. Asthma and COPD. San Diego: Academic Press: 2002. p. 67-78.
22. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998;53:129-36.
23. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long non-smokers with moderate to severe asthma. Eur Respir J 1999;14:892-6.
24. Charan NB, Baile EM. Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10:1173-80.
25. Hogg JC. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999;54:283.
26. Carroll NG, Cooke C, James AL. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997;155:689-95.
27. Orsida BE, Li X, Hickey B, Thien F. Wilson JW, Waiters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999;54:289-95.
28. Fong GH, Rossant J. Gertsenstein M, Breitman ML. Rote of the FIt-1 receplor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70.
29. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in FIk-1-deficient mice. Nature 1995;376:62-6.
30. Li X, Wilson JW, Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156:229-33.
31. Richter A. Puddicombe SM, Lordan JL, Bucchieri F, Wilson SJ, Djukanovic R, et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-nresenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001;25:385-91.
32. Berkman N, Krishnan VL, Gilbey T, Newton R, O'Connor B, Barnes PJ, et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 1996;154:1804-11.
33. Sharma HS, Widyastuti A, Garrelds IM, Hoogsteden HC, Saxena PR, Sterk PJ. Bronchial vascular remodeling in asthma: role of a cytokine mediated angiogenic paracrine pathway. Am J Respir Crit Care Med 2002;165:A810.
34. Corbett L, Stocks J, Pang L, Knox AJ. TGFb increases VEGF release from cultured human airway smooth muscle cells: regulation by steroids and b agonists. Am J Crit Care Med 2002;165:A114.
35. Come J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q. et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000:106:783-91.
36. Redington A, Madden J. Frew AJ. Djukanovic R, Roche WR, Holgate ST, et al. Transforming growth factor-B1 in asthma. Am J Respir Crit Care Med 1997;156:642-7.
37. Vignola AM, Chanez P, Chiappara G, Merendino A. Pace E, Rizzo A, et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156;591-9.
38. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, et al. Eosinophil-assoeiated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997;17:326-33.
39. Renzi PM, Turgeon JP, Marcotte JE, Drblik SP, Berube D, Gagnon MF, et al. Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med 1999;159:1417-22.
40. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocyles. Nature 1996;383:787-93.
41. Gurujeyalakshmi G. Girl SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995;21:791-808.
42. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999;115:176-82.
43. Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 1999;274:15407-14.
44. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001;164:141-8.
45. Hakonarson H, Whelan R, Leiter J, Kim C, Chen M, Campbell D. et al. T lymphocyte-mediated changes in airway smooth muscle responsiveness are attributed to induced autocrine release and actions of IL-5 and IL-1beta. J Allergy Clin 1mmunol 2002;110:624-33.
46. Hirst SJ, Hallsworth MP, Peng Q, Lee TH. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med 2002;165:1161-71.
47. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, Gmnstein JS, et al. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001;281:L1130-7.
48. Ulloa L, Doody J, Massague J, Inhibition of transforming growth factorbeta/SMAD signalling by the interferon-gamm/STAT pathway. Nature 1999;397:710-3.
49. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE, The IL-4 receptor: signaling mechanisms and biologic functions. Anna Rev Immunol 1999;17:701-38.
50. Weltman JK, Karim AS, IL-5: biology and potential therapeutic applications. Expert Opin Investig Drugs 2000;9:491-6.
51. Barnes PJ, Adcock IM. Transcription factors and asthma. Ear Respir J 1998;12:221-34.
52. Karin M, Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 1998;851:139-46.
53. Hirst SJ, Lee TH. Airway smooth muscle as a target of glucoconicoid action in the treatment of asthma. Am J Respir Crit Care Med 1998;158:S201-6.
54. Barnes PJ. Mechanism of action of glucocorticolds in asthma. Am J Respir Crit Care Med 1996;154:S21-7.